Retatrutide Side Effects: Complete Analysis vs Mounjaro and Ozempic

When a new weight management product appears, the first question is always the same: what will happen to my body? Retatrutide is already being called the most powerful product in its class. But power comes at a price, and that's exactly what we'll discuss honestly today.

This material is based on preliminary clinical data, as Retatrutide is still undergoing final research phases. Scientific data on this topic is still limited compared to Mounjaro and Ozempic, but available information allows us to draw important conclusions. For individual risk assessment, we recommend consultation with a DOZA specialist DOZA.

What is Retatrutide and why is it special?

If Ozempic works through one GLP-1 receptor, and Mounjaro through two, then Retatrutide activates three at once. These are GLP-1, GIP, and glucagon receptors. Imagine an orchestra: Ozempic plays one instrument, Mounjaro plays two, and Retatrutide conducts an entire trio.

This triple action explains both the higher efficacy and the somewhat different profile of possible body reactions. The glucagon component adds what's missing in other products. It accelerates fat breakdown directly in the liver and increases energy expenditure. But it can also affect the cardiovascular system and glucose levels differently than familiar GLP-1 agonists.

According to preliminary clinical trial data, participants on the highest Retatrutide doses lost up to 24% of their weight over 48 weeks. This exceeds what Mounjaro shows at maximum dose over a similar period. But with greater efficacy often come more pronounced body reactions, especially during the adaptation phase.

What are the most common body reactions to Retatrutide?

First and foremost: most reactions involve the gastrointestinal tract. This is logical, as all three receptors that Retatrutide affects directly impact the digestive system. Here's what preliminary studies show:

Nausea remains the most common reaction. In the first weeks of use, it's experienced by 30% to 45% of study participants. It's usually most pronounced during the first 2-4 weeks after each dose increase, then gradually decreases. The body adapts, and most people note that by weeks 8-12, nausea becomes minimal or disappears completely.

Diarrhea occurs in approximately 20-30% of participants. This is related to changes in food transit speed through the intestines. GLP-1 and GIP slow gastric emptying but can accelerate movement in lower sections. This effect is usually temporary and well-controlled through dietary adjustments and hydration.

Vomiting is less common than nausea. It's noted by about 10-15% of participants. It's important to understand this isn't a sign of danger, but a reaction to sharp appetite reduction when people still eat usual portions, though the body signals satiety much earlier.

Constipation also occurs in some participants, approximately 15-20%. Slowing gastric motility can affect the intestines too. Adequate water and fiber intake usually resolves this issue.

How does the reaction profile differ from Mounjaro?

This is where it gets really interesting. Mounjaro works through GLP-1 and GIP receptors, while Retatrutide adds glucagon receptors. And this third component creates the differences.

As you can see, Retatrutide demonstrates somewhat higher frequency of gastrointestinal reactions. But important context: this is data from early study phases when titration protocols (gradual dose increases) weren't yet optimized like they are for Mounjaro.

And another fundamental point. The glucagon component of Retatrutide can cause mild increases in heart rate. This is a physiological response to glucagon receptor activation, which stimulates thermogenesis and increases energy expenditure. In most cases, this increase is minimal, 5-10 beats per minute, and has no clinical significance. However, people with cardiovascular conditions should discuss this with a specialist.

If you're interested in a more detailed comparison of Mounjaro and Ozempic, we've prepared a separate material on this topic.

What happens week by week: real experiences

Let's walk through a typical scenario for the first months on Retatrutide. This will help you understand what to expect and how to prepare.

Weeks 1-2: Getting acquainted with the product

The first dose is usually minimal. The body is just getting to know the molecule. Many people notice mild appetite reduction from the first days. Nausea, if it appears, is usually light, more like a feeling of fullness than true nausea. Some experience minor abdominal discomfort.

Advice from our specialists: during this period, the most important thing is learning to listen to your body's signals. If you don't feel like eating, don't force yourself. Reduce portions in advance.

Weeks 3-4: Adaptation period

The body begins responding more seriously to the product. Appetite reduction becomes more pronounced. This is when nausea may intensify, especially if you eat fatty or heavy foods. Diarrhea or constipation may also appear.

Olha, 42, Kyiv: "By the third week, I realized I'd forgotten to have lunch. Just forgot. It was strange and a bit scary, but then came the realization that this is exactly how it should work." From our experience with clients, this moment of clarity comes differently for everyone, but it always comes.

Weeks 5-8: Stabilization

The body adapts. Nausea decreases, digestion normalizes. You begin experiencing steady weight loss. Energy increases, though appetite remains significantly lower than before.

Weeks 9-12: New balance

Most people at this stage no longer experience any discomfort. The body has adjusted. Weight continues to decrease, but now it happens naturally, without struggle.

Who is Retatrutide suitable for, and who should choose another option?

Honesty builds trust, so let's be direct: Retatrutide isn't suitable for everyone. And that's normal. Different products are created for different situations.

Retatrutide may be the optimal choice if:

• You need maximum results and are ready for a more intense adaptation period
• You've already tried other products and want to enhance the effect
• You don't have cardiovascular conditions or contraindications to glucagon activation
• You're ready to work with a specialist for condition monitoring

You might consider Mounjaro if:

• You're just starting your weight correction journey
• You have a sensitive digestive system
• You want a milder reaction profile with high efficacy
• You have cardiovascular risk factors

Learn more about the Mounjaro program on a separate page.

Ozempic would be suitable if:

• You prefer the most studied option
• Predictable reactions are important to you
• You have type 2 diabetes and want to combine glucose control with weight management

How to minimize discomfort: practical recommendations from DOZA specialists

We work with clients on various products and have accumulated significant experience managing body reactions. Here's what really works:

Nutrition:

• Switch to smaller portions before starting the program. This makes the transition smoother
• Avoid fatty, fried, and spicy foods in the first 4-6 weeks
• Eat slowly, chewing thoroughly. This reduces nausea risk
• Prefer protein foods and vegetables
• Don't drink large volumes of liquid during meals

Hydration:

• Drink at least 2 liters of water daily
• Distribute water evenly, not in large portions
• Ginger tea can help with nausea
• Avoid carbonated drinks

Daily routine:

• Give injections on the same day of the week
• Some clients note evening injections are better tolerated
• Don't plan important events the day after injection in the first weeks

Physical activity:

• Light activity, walks, swimming help with nausea
• Don't start intense training in the first weeks
• Listen to your body and don't overload it

Serious reactions: when specialist attention is needed

It's important to distinguish between normal adaptation reactions and signals requiring attention. Most people go through the adaptation period without any problems, but everyone should know these signs.

Consult a specialist if:

• Vomiting doesn't stop for more than 24 hours
• You can't retain even water
• Severe abdominal pain, especially in the upper part
• Yellowing of skin or eyes
• Significantly accelerated heartbeat at rest, more than 100 beats per minute
• Signs of dehydration: severe thirst, dark urine, dizziness
• Any reactions that concern you

With the right approach and professional support, the risk of serious complications is minimal. That's why we emphasize the importance of working with a specialist who can timely adjust the dose or provide recommendations.

Cost and availability comparison

Retatrutide is currently only available through limited programs, as it hasn't received full regulatory approval yet. This means its cost may be higher and availability limited.

Mounjaro, on the contrary, is already fully available in Ukraine. If you're considering this option, here are current prices:

Mounjaro cost is justified by several factors. It's an original Made in UK product with full quality control and cold chain supply. Most importantly, you get not just the product, but full specialist support throughout the entire program. More details about the Mounjaro program cost can be found on a dedicated page.

If you're interested in a broader range of products, including peptides for various purposes, check out our peptides catalog.

What DOZA clients say about the adaptation period

We've collected several reviews from people who went through programs on similar products. Their experience will help understand what to expect:

Iryna, 35, Lviv: "The first two weeks were challenging, with nausea and lack of appetite. But a DOZA specialist supported me daily, adjusted my diet, gave advice. By the end of the first month, I felt nothing except that my jeans became too big."

Maxym, 48, Odesa: "I feared side effects more than they actually turned out to be. Yes, there was mild nausea, but it passed in a week. And the result, minus 18 kg in 4 months, was worth it."

Oksana, 41, Kyiv: "It's important to have realistic expectations. Yes, the first month is challenging. But when you see results on the scale each week, motivation grows. And discomfort seems trivial."

More reviews and results from our clients can be viewed in the special section.

The future of Retatrutide: what to expect?

The scientific community follows Retatrutide research with great interest. Phase 3 clinical trials are already underway, and preliminary results look very promising.

It's expected that during these studies, the titration protocol will be optimized. This means when Retatrutide becomes widely available, recommendations for gradual dose increases will be more detailed, and the reaction profile may improve.

Studies of Retatrutide's impact on fatty liver disease, cardiovascular markers, and other health indicators are also ongoing. Preliminary data suggests the triple mechanism of action may have benefits extending beyond weight correction.

We at DOZA constantly monitor new research and are ready to offer Retatrutide to our clients as soon as it becomes available with full regulatory approval. Subscribe to our blog to stay updated on the news.

Summary: is it worth waiting for Retatrutide?

So, what we know for certain. Retatrutide demonstrates the highest effectiveness among products in its class. Its triple mechanism of action provides results that surpass even Mounjaro. But this effectiveness comes with a somewhat higher frequency of body reactions during the adaptation period.

For some, this is an acceptable compromise. For others, it's better to choose a product with a milder profile. Both positions are absolutely correct. There's no universal solution, there's an individual approach.

Browse the Retatrutide catalog (ALLUVI and SYNEDICA) or learn more on the Retatrutide page.

All this data points to one thing: weight correction today isn't a matter of willpower or miracle diets. It's a matter of choosing the right tool and professional support. If you want to figure out what suits you personally, we're here. A free consultation with a DOZA specialist takes only 5-10 minutes but can change your approach to this issue forever.

Where to order Mounjaro in Ukraine

Ready to start the course? Buy Mounjaro in Ukraine in the DOZA catalog — all 6 doses (2.5, 5, 7.5, 10, 12.5, 15 mg) with official thermal delivery within 24 hours and 24/7 specialist support. Current Mounjaro prices 2026 — from 1,000 ₴ for a test dose or 8,000 ₴/month for a full supervised program.

Where to order DOZA products

DOZA supplies all products mentioned in the article with official cold chain and 24/7 specialist support. Choose what you need:

• Buy Ozempic in Ukraine — original semaglutide from Novo Nordisk with thermal delivery. Current Ozempic prices 2026 — from 1,600 ₴ for a starter dose.

Where to buy

DOZA supplies the products mentioned in this article with an official cold chain and 24/7 specialist support:

• Buy Retatrutide in Ukraine — next-generation triple agonist (GLP-1 + GIP + glucagon), ALLUVI and SYNEDICA pens with cold-chain delivery.